Verapamil Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 51655-959

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51655-959). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 959 52 Rev A 01 23)

Label for Verapamil Hydrochloride Extended-Release Tablets, USP 180 mg, film-coated oral tablets. The package contains 30 tablets and is labeled Rx only. The product is repackaged by Northwind Pharmaceuticals, Indianapolis, IN. Storage instructions and regulatory information are included on the label.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of verapamil hydrochloride, showing aromatic rings with methoxy groups and a nitrile functional group, representing the molecular arrangement of the active ingredient verapamil hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.